Vascular tissue engineering aims to create functional blood vessel substitutes to address the growing burden of cardiovascular diseases, which remain the leading cause of death globally. While autologous grafts have been the gold standard, they are limited by donor site morbidity and availability. Synthetic grafts perform poorly in small-diameter applications due to thrombosis and intimal hyperplasia. Nanofiber-based scaffolds have emerged as a promising solution because they closely mimic the nanoscale architecture of the native extracellular matrix, promoting cell adhesion, proliferation, and differentiation. This article reviews innovative approaches using nanofibers in vascular tissue engineering, covering fabrication methods, material choices, and strategies to enhance graft performance.

Fundamentals of Nanofiber Scaffolds for Vascular Applications

Nanofibers are continuous filaments with diameters ranging from tens to hundreds of nanometers. Their high surface-area-to-volume ratio, interconnected porosity, and tunable mechanical properties make them ideal for recreating the hierarchical structure of native blood vessels. The scaffold must support endothelialization on the luminal surface, provide mechanical strength to withstand hemodynamic forces, and allow smooth muscle cell infiltration and remodeling. Nanofiber mats can be designed with aligned or random fiber orientations to guide cell alignment and tissue organization.

Biomaterials Used in Nanofiber Fabrication

Both natural and synthetic polymers are electrospun into nanofibers. Natural polymers such as collagen, elastin, gelatin, and fibrin offer excellent biocompatibility and bioactivity but often lack mechanical strength. Synthetic polymers like polycaprolactone (PCL), polylactic acid (PLA), poly(lactic-co-glycolic acid) (PLGA), and polyurethane provide tunable degradation rates and mechanical properties. Blends and copolymers combine advantages: for example, PCL-collagen blends improve wettability and cell adhesion while retaining structural integrity. In addition, decellularized extracellular matrix can be processed into nanofibers to preserve native biochemical cues.

Advanced Fabrication Techniques for Nanofiber Scaffolds

Electrospinning remains the most widely used method due to its simplicity, versatility, and ability to produce continuous nanofibers with controlled diameter and alignment. However, recent innovations have extended the capabilities of nanofiber production for vascular grafts.

Coaxial and Emulsion Electrospinning

Coaxial electrospinning uses a dual-needle setup to produce core-shell nanofibers. This allows encapsulation of bioactive molecules (e.g., growth factors, drugs, genes) in the core while the shell provides structural support and controlled release. Emulsion electrospinning achieves similar core-shell structures without specialized nozzles. These techniques enable sustained delivery of vascular endothelial growth factor (VEGF) or heparin to promote endothelialization and prevent thrombosis.

Melt Electrospinning Writing

Melt electrospinning writing (MEW) uses polymer melts rather than solutions, eliminating solvent toxicity and allowing precise deposition of fibers in a computer-controlled pattern. MEW can produce ordered scaffolds with defined pore geometry and fiber alignment, which is advantageous for creating tubular constructs with circumferentially aligned fibers that mimic the medial layer of arteries. The absence of residual solvents also improves biocompatibility.

Self-Assembly and Phase Separation

Peptide amphiphiles and other molecules can self-assemble into nanofibers under physiological conditions. These hydrogels form injectable scaffolds that fill irregular defects. Thermally induced phase separation (TIPS) combined with leaching produces nanofibrous foams with high porosity. While less common than electrospinning, these methods offer unique advantages for in situ gelation or creating three-dimensional constructs with gradient pore sizes.

Key Advantages of Nanofiber Scaffolds in Vascular Grafts

  • Biocompatibility and Reduced Immune Response: Nanofiber scaffolds can be fabricated from naturally derived materials or surface-modified synthetic polymers to present cell-adhesive ligands. This minimizes foreign body reactions and promotes graft integration.
  • Enhanced Cell Growth and Endothelialization: The nanofiber topography mimics the basement membrane of blood vessels, encouraging rapid attachment and migration of endothelial cells. Aligned fibers guide endothelial cell orientation along the direction of blood flow, reducing turbulence and thrombosis risk.
  • Customizability of Mechanical Properties: By adjusting fiber diameter, alignment, porosity, and polymer composition, the scaffold’s burst pressure, compliance, and suture retention can be tailored to match native arteries. For example, bilayered scaffolds with a dense inner layer and porous outer layer mimic the intima and adventitia.
  • Controlled Degradation and Remodeling: Synthetic polymers degrade via hydrolysis, and their degradation rate can be designed to match the pace of new tissue formation. Natural polymers can be crosslinked to tune stability. The gradual transfer of mechanical load from scaffold to neo-tissue improves long-term patency.

Innovative Strategies to Enhance Vascular Graft Performance

Beyond basic scaffold fabrication, researchers have developed sophisticated approaches to overcome the persistent challenges of thrombosis, intimal hyperplasia, and incomplete endothelialization.

Bioactive Coatings and Surface Modifications

Nanofiber surfaces can be functionalized with heparin, nitric oxide donors, or endothelial cell-specific peptides (e.g., REDV, YIGSR) to actively inhibit platelet adhesion and promote endothelial cell capture. Plasma treatment, layer-by-layer assembly, and covalent immobilization are used to attach these molecules without compromising fiber morphology. Studies have shown that heparin-functionalized PCL nanofiber grafts reduce thrombogenicity in vivo.

Incorporation of Growth Factors and Cytokines

Sustained local delivery of VEGF, basic fibroblast growth factor (bFGF), or platelet-derived growth factor (PDGF) from nanofibers accelerates endothelialization and smooth muscle cell infiltration. Dual growth factor delivery systems can coordinate angiogenesis and vessel wall maturation. For instance, VEGF released from the luminal layer promotes rapid endothelial coverage, while PDGF from the outer layer encourages smooth muscle cell migration and remodeling.

Cell Seeding and Pre-Conditioning

Seeding autologous endothelial cells or mesenchymal stem cells onto nanofiber scaffolds before implantation improves graft performance. Dynamic culture in bioreactors that apply cyclic mechanical strain or shear stress enhances cell alignment and extracellular matrix deposition. Pre-conditioned grafts show higher patency rates in animal models compared to acellular scaffolds.

Preclinical and Clinical Progress

Several nanofiber-based vascular grafts have been evaluated in preclinical studies. A notable example is the use of electrospun PCL grafts in rat and sheep models, demonstrating patency up to 12 months with evidence of endothelialization and smooth muscle cell infiltration. More recently, a bilayered electrospun graft combining PCL and collagen showed promising results in a canine carotid artery model, with minimal intimal hyperplasia. Researchers at the University of Pittsburgh are developing a bioabsorbable nanofiber graft that completely remodels into native tissue within six months.

Clinical translation faces hurdles: scaling up manufacturing while maintaining consistency, ensuring sterilization without damaging bioactive components, and obtaining regulatory approval. However, a few products are in early clinical trials. For example, a biodegradable nanofiber scaffold for pediatric heart surgery is being investigated in Europe. The NIH has funded studies on electrospun vascular grafts that highlight the potential for off-the-shelf availability.

Future Directions and Emerging Technologies

Looking ahead, the field is converging with other cutting-edge technologies to create smart, personalized vascular grafts.

3D Bioprinting with Nanofibers

Combining electrospinning with 3D printing allows fabrication of hierarchical structures that integrate nanofiber meshes with larger reinforcing fibers. This can produce compliant grafts with customized geometry for individual patients. Researchers are also developing hybrid printers that simultaneously extrude cell-laden hydrogels and electrospin nanofibers to create living vascular constructs.

Conductive and Responsive Nanofibers

Incorporating conductive polymers like polyaniline or carbon nanotubes into nanofibers enables electrical stimulation of seeded cells, which can enhance alignment and maturation of smooth muscle cells. Additionally, shape-memory polymers can be used to create self-expanding stents or grafts that deploy upon reaching body temperature. Such responsive materials could be triggered by external magnetic fields or ultrasound.

Antimicrobial and Anti-Inflammatory Functionality

Infections remain a serious complication of vascular grafts. Loading nanofibers with antibiotics, silver nanoparticles, or antimicrobial peptides reduces infection risk. Anti-inflammatory agents like dexamethasone can also be incorporated to modulate the foreign body response and prevent excessive fibrosis.

Personalized and Precision Medicine Approaches

Patient-specific scaffolds can be designed using imaging data (CT, MRI) to match the dimensions and mechanical properties of the target vessel. Furthermore, autologous induced pluripotent stem cells (iPSCs) can be differentiated into endothelial cells and seeded onto the graft, minimizing immune rejection. This combination of personalized design and cell therapy represents the ultimate goal of vascular tissue engineering.

Conclusion

Nanofiber technology has revolutionized the field of vascular tissue engineering by providing scaffolds that closely mimic the native extracellular matrix. Advances in fabrication techniques, bioactive agent incorporation, and cell preconditioning have led to preclinical successes and are paving the way for clinical translation. Future innovations in 3D bioprinting, conductive materials, and personalized medicine promise to further improve the durability and functionality of engineered blood vessels. With continued multidisciplinary collaboration, nanofiber-based vascular grafts have the potential to become a standard treatment for patients with cardiovascular disease, reducing reliance on autologous grafts and improving long-term outcomes.

For further reading on recent advances, see this review of electrospun vascular grafts in Acta Biomaterialia and the discussion of growth factor delivery strategies in Advanced Science.